Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study

Background: Eribulin was recently approved in patients progressing after being treated with anthracyclines and taxanes and after two or more chemotherapy lines for advanced disease. Objectives: This multicenter observational retrospective study was performed in order to evaluate activity and tolerab...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamucci, Teresa, Michelotti, Andrea, Pizzuti, Laura, Mentuccia, Lucia, Landucci, Elisabetta, Sperduti, Isabella, Di Lauro, Luigi, Fabi, Alessandra, Tonini, Giuseppe, Sini, Valentina, Salesi, Nello, Ferrarini, Ilaria, Vaccaro, Angela, Pavese, Ida, Veltri, Enzo, Moscetti, Luca, Marchetti, Paolo, Vici, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982178/
https://www.ncbi.nlm.nih.gov/pubmed/24723974
http://dx.doi.org/10.7150/jca.8748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982178/
https://www.ncbi.nlm.nih.gov/pubmed/24723974
http://dx.doi.org/10.7150/jca.8748

Ejemplares similares